NCT01848327View on ClinicalTrials.gov

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Relapsing Remitting MSSecondary Progressive MSPrimary Progressive MS
Interventions
DIETARY_SUPPLEMENT

Caprylic Triglyceride

Caprylic Triglyceride is a medical food that is used for the dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.

DIETARY_SUPPLEMENT

Placebo

Placebo (40 gram packet orally once a day for 90 days)

Trial Locations (1)

33136

University of Miami Miller School of Medicine, Miami

Sponsors

Collaborators (1)

Cerecin
All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

collaborator

Cerecin

INDUSTRY

lead

University of Miami

OTHER

NCT01848327 - Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis | Biotech Hunter | Biotech Hunter